相关实验视频

Updated: Jun 17, 2025

Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet

Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet

Published on: July 31, 2021

基于Beta vulgaris和Eruca sativa的提取物对抗肥胖的作用

Maria Markou^1,2, Antonia Katsouda^1,2, Varvara Papaioannou³

¹Center of Clinical, Experimental Surgery & Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.

Phytotherapy research : PTR

|August 9, 2024

概括

贝塔草和Eruca sativa提取物通过限制体重增加和脂肪积累,显示出抗肥胖作用. 这些发现表明,富含酸盐和硫化物的补充剂可能有助于体重控制.

科学领域:

营养科学营养科学
生物化学生物化学
药理学药理学是指药理学的学科.

背景情况:

肥胖是一个全球性的健康危机,增加非传染性疾病的风险.
绿色的叶菜,富含酸盐和异硫酸酸盐,显示在体重管理方面有前途.
酸盐会产生氧化 (NO),而异硫酸盐会释放硫化 (H2S).

研究的目的:

为了研究Beta vulgaris (甜菜) 和Eruca sativa (鲁古拉) 提取物的抗肥胖潜力.
评估它们对脂质积累,葡萄糖平衡和体重的影响.
探索酸盐和硫化物释放化合物在这些影响中的作用.

主要方法:

选植物提取物对脂肪细胞,肝细胞和骨肌肉培养的影响.
在高脂肪饮食的小鼠体内测试精选提取物.
分析体重,脂肪组织,脂肪细胞大小,基因表达 (Dgat2,PPARγ) 和肝硬化.

主要成果:

在肥胖小鼠中,Beta vulgaris和Eruca sativa提取物显著减弱了体重增加.
治疗减少了白色脂肪组织质量,脂肪细胞大小,改善了肝硬化.
与脂质代谢相关的关键基因表达 (Dgat2,PPARγ) 减少.

结论:

贝塔俗植物和Eruca sativa的提取物显示出显著的抗肥胖特性.
含有酸盐和硫化物释放化合物的食补充剂可能对体重控制有益.
需要进一步的研究来确认对葡萄糖耐受性和血压的影响.

关键词:

甜菜甜菜甜菜硫化是硫化的一种.酸盐酸盐的使用方法肥胖肥胖肥胖肥胖肥胖肥胖肥胖肥胖火箭火箭火箭火箭火箭火箭火箭火箭火箭

更多相关视频

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

Measurement of Basal and Forskolin-stimulated Lipolysis in Inguinal Adipose Fat Pads

Measurement of Basal and Forskolin-stimulated Lipolysis in Inguinal Adipose Fat Pads

Published on: July 21, 2017

相关概念视频

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...

Dose-Response Relationship: Potency and Efficacy

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...

Oral Hypoglycemic Agents: Biguanides and Glitazones

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...